Transient myeloproliferative disorder with partial trisomy 21

Takahide Takahashi(Okayama University Hospital), Akira Shimada(Tohoku University), Kiichiro Kanamitsu(Okayama University Hospital), Akira Inoue(St. Jude Children's Research Hospital), Junko Yoshimoto(Okayama University Hospital), Etsuro Ito(Okayama University), Masahide Imada(Okayama University Hospital), Tsutomu Toki(Hirosaki University), Tomohiko Taki(Kyorin University), Kiminori Terui(Hirosaki University), Mutsuko Yamada(Okayama University Hospital), Shinsuke Ninomiya(Kurashiki Central Hospital)
Pediatric Blood & Cancer
July 1, 2015
10.1002/pbc.25624
Cited by 6

Related Papers

LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).
|PubMed|2002|282
Adenoviral E1A-Associated Protein p300 Is Involved in Acute Myeloid Leukemia With t(11; 22)(q23; q13)
|Blood|1997|262
The t(11;16)(q23;p13) Translocation in Myelodysplastic Syndrome Fuses the MLL Gene to the CBP Gene
|Blood|1997|237
Differential Contributions of<i>BRCA1</i>and<i>BRCA2</i>to Early-Onset Breast Cancer
|New England Journal of Medicine|1997|211
SLUG, a ces-1-Related Zinc Finger Transcription Factor Gene with Antiapoptotic Activity, Is a Downstream Target of the E2A-HLF Oncoprotein
|Molecular Cell|1999|208